                                                                                                                                   I




                                  113TH CONGRESS
                                     1ST SESSION                          H. R. 413
                                  To eliminate the 2-year delay in including oral-only ESRD-related drugs
                                      in the Medicare ESRD prospective payment system, as provided under
                                      section 632(b)(1) of the American Taxpayer Relief Act of 2012.




                                                IN THE HOUSE OF REPRESENTATIVES
                                                               JANUARY 23, 2013
                                  Mr. WELCH (for himself, Mr. HANNA, Mr. COOPER, and Mr. BRALEY of Iowa)
                                      introduced the following bill; which was referred to the Committee on En-
                                      ergy and Commerce, and in addition to the Committee on Ways and
                                      Means, for a period to be subsequently determined by the Speaker, in
                                      each case for consideration of such provisions as fall within the jurisdic-
                                      tion of the committee concerned




                                                                            A BILL
                                  To eliminate the 2-year delay in including oral-only ESRD-
                                     related drugs in the Medicare ESRD prospective pay-
                                     ment system, as provided under section 632(b)(1) of
                                     the American Taxpayer Relief Act of 2012.
                                    1              Be it enacted by the Senate and House of Representa-
                                    2 tives of the United States of America in Congress assembled,





                                    1     SECTION 1. ELIMINATING THE 2-YEAR DELAY IN IMPLE-  2
                                    2                             MENTATION OF ORAL-ONLY ESRD-RELATED
                                    3                             DRUGS IN THE MEDICARE ESRD PROSPEC-
                                    4                             TIVE PAYMENT SYSTEM.
                                    5              Section 632(b) of the American Taxpayer Relief Act
                                    6 of 2012 (Public Law 112–240) is amended by striking all
                                    7 that precedes ‘‘With respect to the implementation’’ and
                                    8 inserting the following::
                                    9              ‘‘(b) MONITORING                    OF        IMPLEMENTATION                    OF   ORAL-
                                  10 ONLY ESRD-RELATED DRUGS                                             IN THE      ESRD PROSPEC-
                                  11      TIVE       PAYMENT SYSTEM.—With respect to the implemen-
                                  12 tation’’.
                                              •HR 413 IH                                   Æ
